US Patent Issued to Icahn School of Medicine at Mount Sinai on Oct. 18 for "Serine threonine kinase (AKT) degradation / disruption compounds and methods of use" (New York Inventors)

Press/Media

Period	19 Oct 2022

Media coverage

Title	US Patent Issued to Icahn School of Medicine at Mount Sinai on Oct. 18 for "Serine threonine kinase (AKT) degradation / disruption compounds and methods of use" (New York Inventors)
Media name/outlet	US Fed News
Country/Territory	United States
Date	19/10/22
URL	metabase.moreover.com/noarticleurl?type=psh&lni=66N5-KNS1-JDKC-R39F-00000-00
Persons	Ramon Parsons, Jing Liu, Jian Jin